Study | Design | Country of origin | N cases |
---|---|---|---|
Amsterdam HF study | Case | Netherlands | 515 |
ARIC | Cohort | USA | 3181 |
ATHENA-HF | RCT | USA | 168 |
BBJ | Japan | 9413 | |
BioSHIFT-TRIUMPH | Case | Netherlands | 619 |
BIOSTAT-CHF | Case-control | Multiple | 4023 |
BioVU | USA | 7726 | |
CARRESS | RCT | USA, Canada | 64 |
CHARM | RCT | Multiple | 2738 |
CHS | Cohort | USA | 1380 |
COGEN | Case-control | Denmark | 1636 |
CORONA | RCT | Multiple | 2815 |
dal-OUTCOMES | RCT | Multiple | 911 |
deCODE | Cohort | Iceland | 20189 |
DiscovEHR | Case-control | USA | 9193 |
DOSE | RCT | USA | 42 |
ELGH | UK | 554 | |
ENGAGE AF-TIMI48 | RCT | Multiple | 6971 |
EPHESUS | RCT-control | Multiple | 1094 |
EPIC-Norfolk | Cohort | UK | 2212 |
EstBiobank | Estonia | 8393 | |
EXACT-HF | RCT | USA | 108 |
FHS | Cohort | USA | 476 |
FIGHT | RCT | USA | 136 |
FINNGEN-r3 | Finland | 13843 | |
FOURIER | USA | 1994 | |
GIANT | USA | 722 | |
GoDARTS | Case-control | UK | 1227 |
GRADE | Case-control | USA | 1060 |
Henry Ford HF cohort | Case | USA | 546 |
HF Action | Case | USA | 453 |
IDEAL | RCT | Multiple | 751 |
INDIE-HFpEF | RCT | USA | 78 |
IRONOUT | RCT | USA | 146 |
LURIC | Case-control | Germany | 1007 |
MAGnet | 2205 | ||
MDCS | Cohort | Sweden | 1770 |
NEAT-HFpEF | RCT | USA | 72 |
ORIGIN | 271 | ||
PARADIGM-HF | RCT | Multiple | 1111 |
PEGASUS-TIMI54 | RCT | Multiple | 2271 |
PIVUS | Cohort | Sweden | 116 |
PREVEND | Cohort | Netherlands | 163 |
PROSPER | RCT | Multiple | 211 |
RELAX | RCT | USA | 142 |
ROSE-AHF | RCT | USA | 192 |
Rotterdam | Cohort | Netherlands | 1839 |
SAVOR-TIMI53 | RCT | Multiple | 1150 |
SHIP | Cohort | Germany | 352 |
SOLID-TIMI52 | RCT | Multiple | 1163 |
TNT | RCT | Multiple | 396 |
TRIUMPH | Case | Netherlands | |
TwinGene | Cohort | Sweden | 604 |
UK Biobank | Cohort | UK | 7299 |
ULSAM | Cohort | Sweden | 288 |
Val-HeFT | RCT | Multiple | 1023 |
WGHS | Cohort | USA | 479 |